Skip to main content
. 2022 May 28;4(7):100493. doi: 10.1016/j.xkme.2022.100493

Table 1.

Demographic and Clinical Characteristics at Baseline

Patient characteristics Total (N = 5,590) Intervention (N = 2,794) Control (N = 2,796) P Value
Age (y), mean (SD) 77.20 (10.90) 77.25 (10.90) 76.96 (10.90) 0.29
Male sex, n (%) 2,173 (38.87%) 1,088 (38.94%) 1,085 (38.81%) 0.90
Race/ethnicity, n (%)
 White 5,397 (96.56%) 2,700 (96.67%) 2,697 (96.46%) 0.67
 Non-White 192 (3.44%) 93 (3.33%) 99 (3.54%)
Marital status, n (%)
 Married 2,544 (45.51%) 1,275 (45.63%) 1,269 (45.39%) 0.84
 Single or other 3,046 (54.49%) 1,519 (54.37%) 1,527 (54.61%)
Tobacco use, n (%)
 Current 379 (6.78%) 192 (6.87%) 187 (6.69%) 0.85
 Former 2,434 (43.54%) 1,225 (43.84%) 1,209 (43.24%)
 Never 2,777 (49.68%) 1,377 (49.28%) 1,400 (50.07%)
Insurance status, n (%)
 Public 4,229 (75.65%) 2,133 (76.34%) 2,096 (74.96%) 0.38
 Private 1,354 (24.22%) 658 (23.55%) 696 (24.89%)
 Self-pay 7 (0.13%) 3 (0.11%) 4 (0.14%)
Diabetes 1,773 (32%%) 879 (32%%) 894 (32%)
Charlson comorbidity index, median (IQR) 2.00 (1.00-4.00) 2.0 (1.0-4.0) 2.0 (1.0-4.0) 0.82
KFRE characteristics
 KFRE risk, median (IQR) 2.30 (1.10-5.60) 2.20 (1.10-5.50) 2.30 (1.20-5.70) 0.35
 KFRE risk >10%, n (%) 840 (15.03%) 419 (15.00%) 421 (15.06%) 0.95

Abbreviations: IQR, Interquartile range; KFRE, kidney failure risk equation; SD, standard deviation.